Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines
Xian‐Sen Huo, Xie‐Er Jian, Jie Ouyang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113449-113449
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy
Mohammed Hawash
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1843-1843
Open Access | Times Cited: 67
Triazole-fused pyrimidines in target-based anticancer drug discovery
Xing‐Jie Dai, Lei-Peng Xue, Shi‐Kun Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115101-115101
Closed Access | Times Cited: 31
The discovery of novel N-heterocyclic-based AKT inhibitors with potential efficacy against prostate cancer
Jinxiao Sun, Dezhi Yang, Yongmi Huang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117435-117435
Closed Access
New Thiazole Carboxamide Derivatives as COX Inhibitors: Design, Synthesis, Anticancer Screening, In Silico Molecular Docking, and ADME Profile Studies
Mohammed Hawash, Nidal Jaradat, Rozan Sabobeh, et al.
ACS Omega (2023) Vol. 8, Iss. 32, pp. 29512-29526
Open Access | Times Cited: 16
Design, synthesis and biological evaluation of CDC20 inhibitors for treatment of triple-negative breast cancer
Shifang Zhao, Jiafu Leng, Shanshan Xie, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116204-116204
Closed Access | Times Cited: 6
Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors
Heba S. Mohamed, Noha H. Amin, Mohammed T. El‐Saadi, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105687-105687
Closed Access | Times Cited: 25
Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway
Jian Song, Shenghui Wang, Chun-Hong Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114583-114583
Closed Access | Times Cited: 25
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities
Jaydeep A. Mokariya, Dhanji P. Rajani, Manish P. Patel
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 22
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Haoxiang Weng, Jinlong Li, Huajian Zhu, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 73-95
Open Access | Times Cited: 12
Rational design, synthesis and biological evaluation of novel 2-(substituted amino)-[1,2,4]triazolo[1,5-a]pyrimidines as novel tubulin polymerization inhibitors
Lin Chen, Tangyang Ji, Xian‐Sen Huo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114864-114864
Closed Access | Times Cited: 21
Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity
Haytham O. Tawfik, Moataz A. Shaldam, Alessio Nocentini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1043-1052
Open Access | Times Cited: 20
Synthesis and biological activity, and molecular modelling studies of potent cytotoxic podophyllotoxin-naphthoquinone compounds
Nguyễn Hà Thành, Quynh Giang Nguyen Thi, Nguyễn Thị Thu Hà, et al.
RSC Advances (2022) Vol. 12, Iss. 34, pp. 22004-22019
Open Access | Times Cited: 19
Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4]triazoles as potent tubulin polymerization inhibitors
Na Li, Qi Guan, Yilang Hong, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115402-115402
Closed Access | Times Cited: 11
Discovery of novel 6-p-tolyl-3-(3,4,5-trimethoxybenzyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivative as a potent tubulin inhibitor with promising in vivo antitumor activity
Tangyang Ji, Xie‐Er Jian, Lin Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115437-115437
Closed Access | Times Cited: 11
Development of tubulin polymerization inhibitors as anticancer agents
Mudasir Nabi Peerzada, Mohammad Sultan Dar, Saurabh Verma
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 797-820
Closed Access | Times Cited: 11
2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response
Moran Sun, Jinling Qin, Yingying Kang, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105625-105625
Closed Access | Times Cited: 16
Synthesis and Antimicrobial Activity Screening of Piperazines Bearing N,N′-Bis(1,3,4-thiadiazole) Moiety as Probable Enoyl-ACP Reductase Inhibitors
Alaa Z. Omar, Najla A. Alshaye, Tawfik M. Mosa, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3698-3698
Open Access | Times Cited: 16
Discovery of novel N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as the inhibitors of tubulin polymerization in leukemia cells
Hui Wu, Longshan Wang, Pei Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115470-115470
Open Access | Times Cited: 9
Design, synthesis and biological evaluation of indole-based [1,2,4]triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors
Cheng-Jun Wu, Jia‐Qiang Wu, Yunfei Hu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113629-113629
Closed Access | Times Cited: 21
Different Synthetic Methods for the Preparation of Triazolopyrimidines and their Biological Profile
Achraf Hibot, Asmaa Oumessaoud, Abderrafia Hafid, et al.
ChemistrySelect (2023) Vol. 8, Iss. 23
Open Access | Times Cited: 8
Design, synthesis, and biological evaluation of N-(pyridin-3-yl)pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapy
Wenbin Zeng, Tangyang Ji, Yanting Zhang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107019-107019
Closed Access | Times Cited: 8
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors
Runlai Liu, Mingxin Huang, Shuai Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113826-113826
Closed Access | Times Cited: 19
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents
Paola Oliva, Romeo Romagnoli, Barbara Cacciari, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1191-1191
Open Access | Times Cited: 12
Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects
Ahmed S. Abdelkhalek, Mohamed S. Attia, Mohammad Amjad Kamal
Current Medicinal Chemistry (2023) Vol. 31, Iss. 14, pp. 1896-1919
Closed Access | Times Cited: 7
Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
Wei Liu, Youyou He, Zhongjie Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top